CytoReason
Michael Frei currently serves as the Director of Finance and FP&A at CytoReason since December 2023. Prior to this role, Michael held various finance leadership positions, including Director of Finance at ArborKnot Ltd., and Finance Director at NI (National Instruments). At OptimalPlus, Michael was responsible for overseeing financial statements, global insurance, and managing a team of accountants as Director of Finance and Accounting. Michael also has experience as a Senior Accountant at Xura, where duties included preparing consolidated financial statements and managing SOX processes. Michael's earlier roles involved consolidation management and intercompany accounting at Comverse Network Systems and Comverse, along with experience as a Senior Associate at PWC. Michael holds a Bachelor’s degree in Economics and Accountancy and a Master of Arts in Law from Bar Ilan University.
This person is not in any teams
This person is not in any offices
CytoReason
5 followers
CytoReason turns human clinical data into clear biology, to deliver data-driven target discovery and drug development. CytoReason’s access to unmatched proprietary and public data, combined with cutting-edge machine learning technologies, creates our unique biological models of disease, tissue and drug.